ArticleBiomaterials translational2026
Chlorin e6-loaded ethosomes for photodynamic wound therapy.
Article in Biomaterials translational, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Improving and optimizing photosensitizers for photodynamic wound therapy remains an urgent task in this field. This study investigates the properties of an ethosomal chlorin e6 (Ce6) photosensitizer and its penetration into various tissues within a wound area. We obtained and analyzed spatial- and geometric configurations, absorption and fluorescence spectra of Ce6 in both molecular and ethosomal forms, alongside studying its penetration into skin and muscle tissue. The synthesized particles were spherical with convex surfaces. The average particle diameter in the samples was 47.7 nm. The absorption and fluorescence spectra of ethosomal Ce6 exhibited a bathochromic shift of 13-16 nm relative to molecular Ce6. This shift in the fluorescence peak was primarily attributed to the presence of lecithin in the ethosomal solution. In contrast, the variability in peak position along the wavelength axis (2-5 nm) was more likely due to ethanol in the solution. Encapsulation of Ce6 in ethosomes overcomes the stratum corneum barrier of the skin, providing 1.5- to 2-fold deeper penetration (up to 180 µm) into the epidermis and papillary dermis compared to free Ce6 (50-120 µm). Upon direct application to muscle tissue, which lacks an epithelial barrier, both formulations penetrate substantially deeper (up to 1500 µm for ethosomal Ce6); however, tissue heterogeneity introduces considerable variability. Therefore, when planning diagnosis or therapy using ethosomal Ce6, it is necessary to select irradiation sources with wavelengths corresponding to these new, shifted absorption peaks, along with appropriate filters for detecting fluorescence in the new spectral range. Furthermore, the potentially greater and more variable depth of tissue saturation compared to skin must be taken into account, as this is a decisive factor in determining the optimal parameters for laser or light-emitting diode irradiation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.